Results 211 to 220 of about 14,058 (258)
Some of the next articles are maybe not open access.

Photochemical degradation of nebivolol in different natural organic matter solutions under simulated sunlight irradiation: Kinetics, mechanism and degradation pathway.

Water Research, 2020
Nebivolol (NEB) is widely used for the treatment of hypertension and chronic heart failure and has become an ubiquitous emerging organic pollutant.
Jieqiong Wang   +3 more
semanticscholar   +1 more source

Protective effects of nebivolol on ovarian ischemia–reperfusion injury in rat

The journal of obstetrics and gynaecology research, 2020
Ovarian torsion is a common gynecological emergency of reproductive ages, occurring at rates of 2.7–7.4%. This study aimed to evaluate the antioxidant effects of Nebivolol (NEB) and histopathological changes in experimental ischemic (I) and ischemic ...
S. Çolak   +5 more
semanticscholar   +1 more source

Pharmaceutical cocrystals of nebivolol hydrochloride with enhanced solubility

, 2020
Nebivolol hydrochloride is an antihypertensive BCS class II drug with low solubility and high permeability prescribed as antihypertensive. Crystal engineering was applied to prepare novel cocrystal forms of nebivolol hydrochloride with general GRAS ...
Vilas J. Nikam, S. Patil
semanticscholar   +1 more source

Evaluation of hepatoprotective effect of Nebivolol and sodium copper Chlorophyllin on CCL4-induced hepatotoxicity in mice.

European Review for Medical and Pharmacological Sciences, 2022
E. Said   +6 more
semanticscholar   +1 more source

Nebivolol

Reactions Weekly, 2023
openaire   +1 more source

Pharmacology of nebivolol.

Journal de pharmacie de Belgique, 1992
Nebivolol is a mixture of equal amounts of two enantiomers: SR3-nebivolol (d-nebivolol) and RS3-nebivolol (l-nebivolol). SR3-nebivolol is a potent and selective beta 1-adrenergic antagonist both in vitro and in vivo. Nebivolol acutely lowers blood pressure in spontaneously hypertensive rats and induces a slight decrease in total peripheral vascular ...
openaire   +2 more sources

Nebivolol

Drug Investigation, 1991
P. J. Blankestijn   +5 more
  +4 more sources

Physiologically-Based Pharmacokinetic Models of CYP2D6 Substrate and Inhibitors Nebivolol, Cinacalcet and Mirabegron to Simulate Drug–Drug Interactions

European journal of drug metabolism and pharmacokinetics, 2022
P. Kilford   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy